VALERIE PETERSON: Open Payments
NPI 1437513397 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 9 payments from 5 companies in 2025. Trend: 2023 $439 · 2024 $723 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $171 |
| Janssen Biotech, Inc. | 2 | $167 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Eisai Inc. | 1 | $22 |
Products named: RYBREVANT, LIBTAYO, KEYTRUDA, Leqembi.
Industry payments across MD — which companies pay providers there.
